Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination

Molecular Medicine Reports

Volumn 4, Issue 5, 2011, Pages 913-918

  Sasaki, Katsunori ^a   Ikuta, Katsuya ^a   Tanaka, Hiroki ^a   Ohtake, Takaaki ^a   Torimoto, Yoshihiro ^a   Fujiya, Mikihiro ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

High performance liquid chromatography; Iron contamination; Non transferrin bound iron; Quantification

Indexed keywords

COBALT DERIVATIVE; IRON; NITRILOTRIACETIC ACID; NON TRANSFERRIN BOUND IRON; REAGENT; TRIS CARBONATOCOBALTATE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; CONTAMINATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; QUANTITATIVE ANALYSIS;

ADULT; ARTIFACTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INDICATORS AND REAGENTS; IRON; MALE; MIDDLE AGED; REFERENCE STANDARDS; SOLUTIONS; TRANSFERRIN; YOUNG ADULT;

EID: 79960383952     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.518     Document Type: Article

References (20)

1. Hershko C, Graham G, Bates GW and Rachmilewitz EA: Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 40: 255-263, 1978. (Pubitemid 9040657)
2. Hershko C: Mechanism of iron toxicity. Food Nutr Bull 28: S500-S509, 2007.
3. Hershko C: Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 1202: 1-9, 2010.
4. Meo A, Ruggeri A, La Rosa MA, Zanghi L, Morabito N and Duca L: Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation. Hemoglobin 30: 131-137, 2006.
5. Breuer W, Hershko C and Cabantchik ZI: The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 23: 185-192, 2000.
6. Dürken M, Nielsen P, Knobel S, et al: Nontransferrin-bound iron in serum of patients receiving bone marrow transplants. Free Radic Biol Med 22: 1159-1163, 1997. (Pubitemid 27171957)
7. Jakeman A, Thompson T, McHattie J and Lehotay DC: Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry. Clin Biochem 34: 43-47, 2001. (Pubitemid 32178504)
8. Zhang D, Okada S, Kawabata T and Yasuda T: An improved simple colorimetric method for quantitation of non-transferrinbound iron in serum. Biochem Mol Biol Int 35: 635-641, 1995. (Pubitemid 26177837)
9. Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J and Hider RC: Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 273: 212-220, 1999. (Pubitemid 29430665)
10. Loreal O, Gosriwatana I, Guyader D, Porter J, Brissot P and Hider RC: Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 32: 727-733, 2000. (Pubitemid 30262731)
11. Gutteridge JM and Hou YY: Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron. Free Radic Res Commun 2: 143-151, 1986.
12. Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C and Cabantchik ZI: The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 95: 2975-2982, 2000. (Pubitemid 30235912)
13. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C and Cabantchik ZI: Deferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 97: 792-798, 2001. (Pubitemid 32113415)
14. Breuer W and Cabantchik ZI: A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem 299: 194-202, 2001. (Pubitemid 34053410)
15. Porter JB, Abeysinghe RD, Marshall L, Hider RC and Singh S: Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88: 705-713, 1996. (Pubitemid 26240403)
16. De Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC and Marx JJ: Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30: 248-251, 2000. (Pubitemid 30153666)
17. Dobbin PS, Hider RC, Hall AD, et al: Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)- pyridinones: orally active iron chelators with clinicalpotential. J Med Chem 36: 2448-2458, 1993.
18. Aisen P, Enns C and Wessling-Resnick M: Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 33: 940-959, 2001. (Pubitemid 32706687)
19. Jacobs EM, Hendriks JC, van Tits BL, et al: Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform. Anal Biochem 341: 241-250, 2005. (Pubitemid 40724808)
20. Bradley SJ, Gosriwitana I, Srichairatanakool S, Hider RC and Porter JB: Non-transferrin-bound iron induced by myeloablative chemotherapy. Br J Haematol 99: 337-343, 1997. (Pubitemid 27497564)